PHARMDEKO - Pharma-Deko Plc
Manufacturing and Marketing of Pharmaceutical & Consumer Products
Pharma-Deko Plc is listed on the Nigerian Stock Exchange (NGX). Pharma-Deko is traded on the NGX under the ticker symbol “PHARMDEKO”. The International Securities Identification Number (ISIN) of NGX:PHARMDEKO is NGPHARMDEKO7. Pharma-Deko Plc is currently the 146th most valuable stock on the NGX with a market capitalization of NGN 347 million, which makes about 0.0012% of the Nigerian Stock Exchange equity market.
|Last Trading Results|
|Day’s Low Price|
|Day’s High Price|
|Number of Deals||0|
|Growth & Valuation|
|Earnings Per Share|
|Dividend Per Share|
PHARMDEKO Stock Market Performance
The current share price of Pharma-Deko Plc (PHARMDEKO) is NGN 1.60. PHARMDEKO closed its last trading day (Wednesday, May 18, 2022) at 1.60 NGN per share on the Nigerian Stock Exchange (NGX). Pharma-Deko began the year with a share price of 2.20 NGN but has since lost 27.3% off that price valuation, ranking it 153rd on the NGX in terms of year-to-date performance.
Pharma-Deko is the 93rd most traded stock on the Nigerian Stock Exchange over the past three months (Feb 16 - May 19, 2022). PHARMDEKO has traded a total volume of 10.7 million shares—in 272 deals—valued at NGN 19.4 million over the period, with an average of 170,508 traded shares per session. A volume high of 2.13 million was achieved on February 17th for the same period. The table below details the last 10 trading days of activity of Pharma-Deko on the Nigerian Stock Exchange.
Profile of Pharma-Deko Plc
Pharma-Deko Plc operates in the Health Care sector.
Factsheet of Pharma-Deko Plc
- Health Care
PHARMDEKO Industrial Market Competitors
Pharma-Deko Plc, issuers of the PHARMDEKO stock on the Nigerian Stock Exchange, have six market competitors who are also engaged in the Health Care sector. The table below presents an overview of their market standing.
|GLAXOSMITH||Glaxo Smithkline Consumer||8.37B||7.00||+17.7%|
|MAYBAKER||May & Baker Nigeria||7.44B||4.31||+7.21%|
|NEIMETH||Neimeth International Pharma||3.04B||1.60||-8.57%|